Format

Send to

Choose Destination
AAPS J. 2008;10(1):200-7. doi: 10.1208/s12248-008-9019-6. Epub 2008 Apr 5.

Reaction phenotyping: current industry efforts to identify enzymes responsible for metabolizing drug candidates.

Author information

1
Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb, PO Box 5400, Mail Stop 17-12, Princeton, New Jersey 08543-5400, USA. timothy.harper@bms.com

Abstract

Reaction phenotyping studies to identify specific enzymes involved in the metabolism of drug candidates are increasingly important in drug discovery efforts. Experimental approaches used for CYP reaction phenotyping include incubations with cDNA expressed CYP enzyme systems and incubations containing specific CYP enzyme inhibitors. Since both types of experiments present specific advantages as well as known drawbacks, these studies are generally viewed as complementary approaches. Although glucuronidation pathways are also known to present potential drug-drug interaction issues as well as challenges related to their polymorphic expression, reaction phenotyping approaches for glucuronidation are generally limited to cDNA expressed systems due to lack of availability of specific UGT inhibitors. This article presents a limited review of current approaches to reaction phenotyping studies used within the pharmaceutical industry.

PMID:
18446520
PMCID:
PMC2751464
DOI:
10.1208/s12248-008-9019-6
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center